Purple Biotech Stock Forward View - Simple Exponential Smoothing
| PPBT Stock | USD 0.60 0.02 3.23% |
Purple Stock outlook is based on your current time horizon.
At this time, the RSI of Purple Biotech's share price is approaching 37 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Purple Biotech, making its price go up or down. Momentum 37
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.26) | EPS Estimate Current Year (1.16) | EPS Estimate Next Year (0.62) | Wall Street Target Price 34 | EPS Estimate Current Quarter (0.21) |
Using Purple Biotech hype-based prediction, you can estimate the value of Purple Biotech from the perspective of Purple Biotech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Purple Biotech using Purple Biotech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Purple using crowd psychology based on the activity and movement of Purple Biotech's stock price.
Purple Biotech Implied Volatility | 0.91 |
Purple Biotech's implied volatility exposes the market's sentiment of Purple Biotech stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Purple Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Purple Biotech stock will not fluctuate a lot when Purple Biotech's options are near their expiration.
The Simple Exponential Smoothing forecasted value of Purple Biotech on the next trading day is expected to be 0.60 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.34. Purple Biotech after-hype prediction price | USD 0.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Purple Biotech to cross-verify your projections. Prediction based on Rule 16 of the current Purple contract
Based on the Rule 16, the options market is currently suggesting that Purple Biotech will have an average daily up or down price movement of about 0.0569% per day over the life of the 2026-03-20 option contract. With Purple Biotech trading at USD 0.6, that is roughly USD 3.41E-4 . If you think that the market is fully incorporating Purple Biotech's daily price movement you should consider acquiring Purple Biotech options at the current volatility level of 0.91%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Purple Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Purple Biotech's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Purple Biotech's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Purple Biotech stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Purple Biotech's open interest, investors have to compare it to Purple Biotech's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Purple Biotech is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Purple. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Purple Biotech Additional Predictive Modules
Most predictive techniques to examine Purple price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Purple using various technical indicators. When you analyze Purple charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Purple Biotech Simple Exponential Smoothing Price Forecast For the 3rd of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Purple Biotech on the next trading day is expected to be 0.60 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0009, and the sum of the absolute errors of 1.34.Please note that although there have been many attempts to predict Purple Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Purple Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Purple Biotech Stock Forecast Pattern
| Backtest Purple Biotech | Purple Biotech Price Prediction | Research Analysis |
Purple Biotech Forecasted Value
In the context of forecasting Purple Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Purple Biotech's downside and upside margins for the forecasting period are 0.01 and 4.58, respectively. We have considered Purple Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Purple Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Purple Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.3065 |
| Bias | Arithmetic mean of the errors | 0.0043 |
| MAD | Mean absolute deviation | 0.0223 |
| MAPE | Mean absolute percentage error | 0.0297 |
| SAE | Sum of the absolute errors | 1.34 |
Predictive Modules for Purple Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Purple Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Purple Biotech After-Hype Price Density Analysis
As far as predicting the price of Purple Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Purple Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Purple Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Purple Biotech Estimiated After-Hype Price Volatility
In the context of predicting Purple Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Purple Biotech's historical news coverage. Purple Biotech's after-hype downside and upside margins for the prediction period are 0.03 and 4.55, respectively. We have considered Purple Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Purple Biotech is abnormally volatile at this time. Analysis and calculation of next after-hype price of Purple Biotech is based on 3 months time horizon.
Purple Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Purple Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Purple Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Purple Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.51 | 3.98 | 0.03 | 0.00 | 5 Events / Month | 5 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.60 | 0.60 | 0.00 |
|
Purple Biotech Hype Timeline
Purple Biotech is at this time traded for 0.60. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.0. Purple is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.51%. %. The volatility of related hype on Purple Biotech is about 66444.07%, with the expected price after the next announcement by competition of 0.60. The company has price-to-book ratio of 0.17. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Purple Biotech recorded a loss per share of 45.9. The entity last dividend was issued on the 21st of August 2020. The firm had 1:20 split on the 17th of September 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out Historical Fundamental Analysis of Purple Biotech to cross-verify your projections.Purple Biotech Related Hype Analysis
Having access to credible news sources related to Purple Biotech's direct competition is more important than ever and may enhance your ability to predict Purple Biotech's future price movements. Getting to know how Purple Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Purple Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SYRS | Syros Pharmaceuticals | 0.17 | 9 per month | 30.25 | 0.26 | 300.00 | (75.00) | 375.00 | |
| AKTX | Akari Therapeutics PLC | 0.01 | 7 per month | 0.00 | (0.20) | 8.57 | (12.50) | 51.79 | |
| CDT | Conduit Pharmaceuticals | 0.07 | 7 per month | 0.00 | (0.22) | 10.06 | (11.97) | 32.20 | |
| XAGE | Longevity Health Holdings | (0.13) | 10 per month | 0.00 | (0.06) | 18.75 | (20.45) | 46.80 | |
| DRMA | Dermata Therapeutics | (0.15) | 9 per month | 0.00 | (0.05) | 16.18 | (16.23) | 58.17 | |
| REVB | Revelation Biosciences | 0.00 | 8 per month | 0.00 | (0.24) | 6.12 | (9.09) | 35.57 | |
| MSPR | MSP Recovery | (0.06) | 8 per month | 0.00 | (0.02) | 46.34 | (36.84) | 200.36 | |
| PBM | Psyence Biomedical Ltd | 0.03 | 9 per month | 0.00 | (0.24) | 9.41 | (13.79) | 96.66 | |
| FOXO | FOXO Technologies | 0.00 | 5 per month | 21.14 | 0.09 | 100.00 | (50.00) | 216.67 | |
| VINC | Vincerx Pharma Common | 0.0001 | 1 per month | 13.81 | 0.03 | 10.00 | (4.48) | 127.90 |
Other Forecasting Options for Purple Biotech
For every potential investor in Purple, whether a beginner or expert, Purple Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Purple Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Purple. Basic forecasting techniques help filter out the noise by identifying Purple Biotech's price trends.Purple Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Purple Biotech stock to make a market-neutral strategy. Peer analysis of Purple Biotech could also be used in its relative valuation, which is a method of valuing Purple Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Purple Biotech Market Strength Events
Market strength indicators help investors to evaluate how Purple Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Purple Biotech shares will generate the highest return on investment. By undertsting and applying Purple Biotech stock market strength indicators, traders can identify Purple Biotech entry and exit signals to maximize returns.
Purple Biotech Risk Indicators
The analysis of Purple Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Purple Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting purple stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.73 | |||
| Semi Deviation | 4.3 | |||
| Standard Deviation | 11.28 | |||
| Variance | 127.28 | |||
| Downside Variance | 26.44 | |||
| Semi Variance | 18.51 | |||
| Expected Short fall | (8.67) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Purple Biotech
The number of cover stories for Purple Biotech depends on current market conditions and Purple Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Purple Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Purple Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Purple Biotech Short Properties
Purple Biotech's future price predictability will typically decrease when Purple Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Purple Biotech often depends not only on the future outlook of the potential Purple Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Purple Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.6 M | |
| Cash And Short Term Investments | 8.5 M |
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.